Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Mar 4;2(1):2.
doi: 10.1186/2049-9256-2-2. eCollection 2014.

HIV-associated neurocognitive disorders

Montserrat Sanmarti  1 , Laura Ibáñez  2 , Sonia Huertas  3 , Dolors Badenes  3 , David Dalmau  1 , Mark Slevin  4 , Jerzy Krupinski  5 , Aurel Popa-Wagner  6 , Angeles Jaen  2
Affiliations
Review

HIV-associated neurocognitive disorders

Montserrat Sanmarti et al. J Mol Psychiatry. .

Abstract

Currently, neuropsychological impairment among HIV+ patients on antiretroviral therapy leads to a reduction in the quality of life and it is an important challenge due to the high prevalence of HIV-associated neurocognitive disorders and its concomitant consequences in relation to morbidity and mortality- including those HIV+ patients with adequate immunological and virological status. The fact that the virus is established in CNS in the early stages and its persistence within the CNS can help us to understand HIV-related brain injury even when highly active antiretroviral therapy is effective. The rising interest in HIV associated neurocognitive disorders has let to development new diagnostic tools, improvement of the neuropsychological tests, and the use of new biomarkers and new neuroimaging techniques that can help the diagnosis. Standardization and homogenization of neurocognitive tests as well as normalizing and simplification of easily accessible tools that can identify patients with increased risk of cognitive impairment represent an urgent requirement. Future efforts should also focus on diagnostic keys and searching for useful strategies in order to decrease HIV neurotoxicity within the CNS.

Keywords: HAND; HIV; Neurocognitive disorders.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Algorithm for the detection and evaluation of HAND.
See this image and copyright information in PMC

References

    1. Report of a Working Group of the American Academy of Neurology AIDS Task force Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 infection. Neurology. 1991;41:778–785. doi: 10.1212/WNL.41.6.778. - DOI - PubMed
    1. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epsteins LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, price RW, Pulliam L, Roberston KR, Sacktor N, Valcour V, Wojna VE. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69:1789–1799. doi: 10.1212/01.WNL.0000287431.88658.8b. - DOI - PMC - PubMed
    1. Woods SP, More DJ, Weber E, Grant I. Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev. 2009;19:152–168. doi: 10.1007/s11065-009-9102-5. - DOI - PMC - PubMed
    1. Valcour V, Chalermchai T, Sailasuta N, Marovich M, Lerdlum S, Suttichom D, Suwanwela NC, Jagodzinski L, Michael N, Spudich S, Griensven FV, de Souza M, Kim J, Ananworanich J. Central nervous system viral invasión and inflammation during acute HIV infection. J Infect Dis. 2012;206:275–282. doi: 10.1093/infdis/jis326. - DOI - PMC - PubMed
    1. Spudich S, Gonzalex-Scarano F. HIV-1 realted central nervous system disease: current issues in pathogenesis, diagnosis and treatment. Cold Spring Harb Perspect Med. 2012;2:a007120. doi: 10.1101/cshperspect.a007120. - DOI - PMC - PubMed